In this podcast, Brian Wojciechowski, MD, Breastcancer.org medical adviser, discusses some of the research that was published in July 2014.
In this podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in July 2014. Listen to the podcast to hear Dr. Wojciechowski talk about:
Running time: 20:50
Tucatinib Continues to Show Benefit in Pretreated HER2+ Breast Cancer With Brain Metastases
December 7th 2023The primary analysis of the phase 3 HER2CLIMB-02 demonstrates that tucatinib slowed disease progression in patients with HER2-positive metastatic breast cancer, including those with brain metastases.